AngioDynamics: Growth Remains Under The Radar

2025-12-29 18:47:22 ET

Slow progress is still progress, and although AngioDynamics ( ANGO ) arguably still does not get its due in the market, the company continues to execute at an improved level. Solid growth in the faster-growing Medical Tech segment remains the key driver, as the company has credible growth leverage in peripheral atherectomy, embolectomy, and less-invasive cancer treatment, but better margins would certainly help the story....

Read the full article on Seeking Alpha

For further details see: